Proteins predict significant step toward development of Type 1 diabetes
Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.
This author has yet to write their bio.
Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.
A study of more than 22,000 people with multiple sclerosis has discovered the first genetic variant associated with faster disease progression, which can rob patients of their mobility and independence over time.
Siemens Healthineers is now selling two new solutions for high-volume haematology testing, the Atellica HEMA 570 Analyzer and the Atellica HEMA 580 Analyzer. Vital to patient care, the complete blood count (CBC) is among the most performed diagnostic tests in the lab and often provides the first indication of illness in a patient.
Torrey Pines Scientific has introduced the EchoTherm Models HP51 and HS51 Digital Hot Plates and Digital Stirring Hot Plates – designed for large samples. The units feature membrane keyboards and full function liquid crystal displays where all parameters are continuously visible. These units can store two of the user’s favourite settings in memory for instant […]
AFYS3G has launched a new capping solution for the automatic closing of single sample tubes: the AFYS3G Capper for Screw Cap Tubes Sigma STR. The Sigma STR is designed to improve efficiency and can be used as stand-alone device. The capper for single screw cap tubes is a reliable and durable instrument for any lab […]
The EURORealTime SARS-CoV-2 from EUROIMMUN is now validated for use with saliva as sample material as an alternative to throat swabs. Collection of saliva specimens is easier and less distressing for patients than taking nasal or throat swabs, especially for children.
H.E.L Group has expanded its BioXplorer range with the introduction of two new automated parallel bioreactors: BioXplorer 400XL and BioXplorer 400P. The new systems will further enable the efficient and cost-effective development and optimization of bioprocesses.
Biotium has released Mix-n-Stain CF Dye IgM antibody labelling kits. These kits revolutionize the labelling process for IgM antibodies, enabling researchers to easily obtain high-performance fluorescent IgM conjugates with minimal hands-on time with no purification after labelling.
Revvity’s EUROIMMUN business has launched the UNIQO 160, an automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics. Now available in countries accepting the CE mark, this all-in-one solution increases the efficiency of the entire IIFT process, encompassing sample preparation, incubation, washing and mounting of slides as well as image acquisition and analysis.
Oncodesign Services, a leading Contract Research Organization specialized in drug discovery and preclinical services in oncology and immuno-inflammation, has executed a Preclinical License and Supply Agreement with ImaginAb for the use of their investigational CD8 ImmunoPET (89Zr crefmirlimab berdoxam) technology. ImaginAb, a biotechnology company, developed CD8 ImmunoPET, a 89Zr PET imaging agent to enable the […]
November 2025
The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy